Noven Pharmaceuticals recalls
Noven Pharmaceuticals has 51 recalls on record with the FDA and USDA, the earliest in 2012 and the latest reported on 27 Nov 2024. 12 are still ongoing. The most frequent reason is potency & assay.
Total recalls51since 2012
Last 12 months0reported
Class I00% of total
Ongoing12latest 27 Nov 2024
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 50 98%Class III 1 2%
Why noven pharmaceuticals is recalled
Product types
Brands
By year
Ongoing noven pharmaceuticals recalls
12 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Xelstrym (dextroamphetamine) transdermal system recalledXelstrym | Noven Pharmaceuticals | Packaging Defects | Nationwide |
| Drug | CLASS II | Daytrana (methylphenidate transdermal system) CII, 20mg recalledDaytrana | Noven Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Daytrana (methylphenidate transdermal system) CII, 15 mg recalledDaytrana | Noven Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Daytrana (methylphenidate transdermal system) CII, 10mg recalledDaytrana | Noven Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Daytrana (methylphenidate transdermal system) CII, 30 mg recalledDaytrana | Noven Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS II | Daytrana (methylphenidate transdermal system) recalledDaytrana | Noven Pharmaceuticals | Potency & Assay | Nationwide |
All noven pharmaceuticals recalls, newest first
51 totalAbout this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.